152 related articles for article (PubMed ID: 3699082)
1. Carcinoembryonic antigen (CEA) and alkaline phosphatase in progressive colorectal cancer with special reference to patient survival.
Aabo K; Pedersen H; Kjaer M
Eur J Cancer Clin Oncol; 1986 Feb; 22(2):211-7. PubMed ID: 3699082
[TBL] [Abstract][Full Text] [Related]
2. Serial plasma carcinoembryonic antigen measurements in the management of metastatic colorectal carcinoma.
Shani A; O'Connell MJ; Moertel CG; Schutt AJ; Silvers A; Go VL
Ann Intern Med; 1978 May; 88(5):627-30. PubMed ID: 646245
[TBL] [Abstract][Full Text] [Related]
3. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
Bakalakos EA; Burak WE; Young DC; Martin EW
Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
[TBL] [Abstract][Full Text] [Related]
4. The use of preoperative plasma CEA levels for the Stratification of patients after curative resection of colorectal cancers.
Goslin R; Steele G; Macintyre J; Mayer R; Sugarbaker P; Cleghorn K; Wilson R; Zamcheck N
Ann Surg; 1980 Dec; 192(6):747-51. PubMed ID: 7447529
[TBL] [Abstract][Full Text] [Related]
5. [Using CEA for diagnostic, therapeutic and prognostic evaluation in colorectal cancers].
Terabe K; Ichihashi H; Kamei H; Kondo T
Gan To Kagaku Ryoho; 1984 Jan; 11(1):111-6. PubMed ID: 6696454
[TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen in management of colorectal carcinoma.
Booth SN; Jamieson GC; King JP; Leonard J; Oates GD; Dykes PW
Br Med J; 1974 Oct; 4(5938):183-7. PubMed ID: 4421372
[TBL] [Abstract][Full Text] [Related]
7. Screening for liver metastases from colorectal cancer with carcinoembryonic antigen and alkaline phosphatase.
Tartter PI; Slater G; Gelernt I; Aufses AH
Ann Surg; 1981 Mar; 193(3):357-60. PubMed ID: 7212797
[TBL] [Abstract][Full Text] [Related]
8. Unresectable hepatic metastases from carcinoma of the colon and rectum.
Didolkar MS; Elias EG; Whitley NO; Keramati B; Jackson AJ; Hebel RJ; Jordan TE
Surg Gynecol Obstet; 1985 May; 160(5):429-36. PubMed ID: 3992446
[TBL] [Abstract][Full Text] [Related]
9. Carcinoembryonic antigen: clinical and historical aspects.
Martin EW; Kibbey WE; DiVecchia L; Anderson G; Catalano P; Minton JP
Cancer; 1976 Jan; 37(1):62-81. PubMed ID: 1247968
[TBL] [Abstract][Full Text] [Related]
10. Correlation between the results of carcinoembryonal antigen (CEA) test and the clinical stage of colorectal carcinoma.
Molnár L; Rahóty P; Bauer E; Rónay P; Besznyák I; Ottó S
Acta Chir Hung; 1986; 27(1):27-34. PubMed ID: 3716715
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen in patients with colorectal cancer: correlation between stage of disease and antigen level.
Bartal AH; Ayalon D; Cordova T; Avidan S; Robinson E
Isr J Med Sci; 1983 Sep; 19(9):801-5. PubMed ID: 6643017
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of adenocarcinomas of the colorectum with low levels of preoperative plasma carcinoembryonic antigen (CEA).
Jubert AV; Talbott TM; Maycroft TM
Cancer; 1978 Aug; 42(2):635-9. PubMed ID: 679156
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of CEA in colorectal cancer: a statistical study.
Persijn JP; Hart AA
J Clin Chem Clin Biochem; 1981 Nov; 19(11):1117-23. PubMed ID: 7310333
[TBL] [Abstract][Full Text] [Related]
14. Tumor markers in colorectal carcinoma. An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase and pseudouridine.
Rasmuson T; Björk GR; Damber L; Holm SE; Jacobsson L; Jeppsson A; Stigbrand T; Westman G
Acta Radiol Oncol; 1984; 23(1):27-32. PubMed ID: 6328884
[TBL] [Abstract][Full Text] [Related]
15. Doubling time of circulating cea and its relation to survival of patients with recurrent colorectal cancer.
Staab HJ; Anderer FA; Hornung A; Stumpf E; Fischer R
Br J Cancer; 1982 Nov; 46(5):773-81. PubMed ID: 7171456
[TBL] [Abstract][Full Text] [Related]
16. CEA as a monitor of gastrointestinal malignancy.
Holyoke ED; Chu TM; Murphy GP
Cancer; 1975 Mar; 35(3):830-6. PubMed ID: 1111949
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of plasma CEA in patients with colorectal carcinoma.
Koch M; McPherson TA
J Surg Oncol; 1979 Dec; 12(4):319-25. PubMed ID: 522488
[TBL] [Abstract][Full Text] [Related]
18. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer?
Wanebo HJ
Surgery; 1981 Mar; 89(3):290-5. PubMed ID: 7466616
[TBL] [Abstract][Full Text] [Related]
19. A comparison of fast homoarginine-sensitive alkaline phosphatase and carcinoembryonic antigen as markers in colon carcinoma.
Larson FC; Kahan L; Tormey DC; Davis TE
J Clin Oncol; 1984 May; 2(5):457-61. PubMed ID: 6726299
[TBL] [Abstract][Full Text] [Related]
20. Colon-specific antigen-p (CSAp). I. Initial clinical evaluation as a marker for colorectal cancer.
Pant KD; Shochat D; Nelson MO; Goldenberg DM
Cancer; 1982 Sep; 50(5):919-26. PubMed ID: 6178498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
